Financials
| Div Yield |
3.1% |
7.8% |
| Div Cover |
2.54 |
n/a |
| Op Mrgn |
70.0% |
n/a |
| ROCE |
69.0% |
|
| P/E |
62.99 |
16.50 |
| PEG |
2.93 |
2.81 |
| Pr/Revenue |
11.17 |
n/a |
| Pr/Book |
3.96 |
|
| Revenue |
6.1% |
n/a |
| PBT |
25.5% |
n/a |
| EPS |
8.0% |
243.7% |
| DPS |
14.6% |
|
| 1 week |
10,353.84 |
+131.17 |
+1.27% |
| 1 month |
10,485.01 |
0.00 |
n/a |
| 3 months |
9,675.43 |
+809.58 |
+8.37% |
| 6 months |
9,138.90 |
+1,346.11 |
+14.73% |
| 1 year |
8,768.01 |
+1,717.00 |
+19.58% |
| IMB | 16-Feb-26 |
Sell |
Murray McGowan |
3,230.42p | 15,955 |
£515,413.50 |
| IMB | 16-Feb-26 |
Exercise of option |
Murray McGowan |
0.000p | 33,794 |
£0.00 |
| IMB | 16-Feb-26 |
Sell |
Lukas Paravicini |
3,219.00p | 30,561 |
£983,758.55 |
| BTRW |
385.30p |
+3.0% |
| AAF |
345.00p |
+2.6% |
| REL |
2,226.00p |
+2.4% |
| PSON |
921.00p |
+1.9% |
| PSN |
1,529.50p |
+1.7% |
| GSK |
2,216.00p |
+1.5% |
| LAND |
659.00p |
+1.3% |
| EXPN |
2,502.00p |
+1.3% |
| LGEN |
272.90p |
+1.2% |
| CNA |
195.85p |
+1.2% |
| ANTO |
3,572.00p |
-4.6% |
| WEIR |
3,384.00p |
-3.6% |
| FRES |
3,698.00p |
-3.0% |
| AAL |
3,474.00p |
-2.9% |
| GLEN |
480.55p |
-2.5% |
| BAB |
1,320.00p |
-1.9% |
| RR. |
1,273.00p |
-1.9% |
| IMI |
2,770.00p |
-1.8% |
| MRO |
655.40p |
-1.7% |
| RIO |
6,994.00p |
-1.6% |
Top of Page
You are here:
research